Wells Fargo upgrades Arvinas to overweight ahead of Phase 3 data readout
https://seekingalpha.com/news/4048140-wells-fargo-upgrades-arvinas-to-overweight-ahead-of-phase-3-data-readout?source=feed_sector_healthcare
Dec 19, 2023 -
0
Japan Trade Data On Tap For Wednesday
https://www.rttnews.com/3412302/japan-trade-data-on-tap-for-wednesday.aspx?type=alleco
Dec 19, 2023 - Japan will on Wednesday release November numbers for imports, exports and trade balance, highlighting a light day for Asia-Pacific economic activity.
0
RedHill shares rally 20% on positive data for two antiviral drugs
https://seekingalpha.com/news/4048562-redhill-shares-rally-on-positive-data-for-two-antiviral-drugs?source=feed_sector_healthcare
Dec 20, 2023 - RedHill Biopharma (RDHL) shares soared 20% on positive results from a laboratory study of its drugs opaganib and RHB-107 in combination with remdesivir. Read more here.
0
European Economic News Preview: UK Public Sector Finance Data Due
https://www.rttnews.com/3412909/european-economic-news-preview-uk-public-sector-finance-data-due.aspx?type=alleco
Dec 20, 2023 - Public sector finance data from the UK is due on Thursday, headlining a light day for the European economic news. At 2.00 am ET, the Office for National Statistics releases UK public sector net borrowing data for November. The budget deficit is forecast to narrow to GBP 12.9 billion from GBP 14.9 billion in October.
0
Brunswick discloses further details about previously reported data security incident
https://seekingalpha.com/news/4049483-brunswick-discloses-further-details-about-previously-reported-data-security-incident?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Dec 21, 2023 - Brunswick (BC) reveals limited exposure of sensitive personal data in recent data security incident; no misuse reported, according to company statement.
0
Immunovant stock jumps 9% on positive data for Graves' disease drug
https://seekingalpha.com/news/4049179-immunovant-stock-jumps-on-positive-data-for-graves-disease-drug?source=feed_sector_healthcare
Dec 21, 2023 - Immunovant (IMVT) stock jumped 9% in the wake of positive Phase 2 data for its drug candidate batoclimab in the treatment of Graves' disease. Read more here.
0
U.S. Stocks Moving Moderately Higher Following Inflation Data
https://www.rttnews.com/story.aspx?Id=3413336
Dec 22, 2023 - Following the significant rebound seen in the previous sessions, stocks have seen some further upside during trading on Friday. The major averages have all moved higher, largely offsetting the sharp pullback seen on Wednesday.
0
Tamer-Than-Expected Inflation Data May Lead To Extended Rebound On Wall Street
https://www.rttnews.com/story.aspx?Id=3413310
Dec 22, 2023 - The major U.S. index futures are currently pointing to a slightly higher open on Friday, with stocks likely to extend the significant rebound seen in the previous session.
0
Cytokinetics may be worth $90+ a share in potential deal amid Phase 3 data - UFP
https://seekingalpha.com/news/4050555-cytokinetics-may-be-worth-90-in-potential-acquistion-after-phase-3-data?source=feed_sector_healthcare
Dec 27, 2023 - Cytokinetics may be worth $90/share in a potential takeover after its shares surged 68% on positive Phase 3 trial data for its cardiac myosin inhibitor,...
0
TScan: Two 2024 TCR-T Data Readouts Could Bring Significant Value
https://seekingalpha.com/article/4660017-tscan-two-2024-tcr-t-data-readouts-could-bring-significant-value?source=feed_all_articles
Dec 27, 2023 - TScan's results from T-Plex targeting patients with solid tumors in the Phase 1 study are expected to be released in 2024. Read my analysis of TCRX stock.
0